JANX
#2397
Janux Therapeutics, Inc. - Common Stock
18.0 1 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.10%
Monthly Change
+20.71%
6 month change
+35.41%
Year Change
-22.03%
Previous Close
18.7 8
Open
18.0 0
Low
17.9 7
High
18.1 0
Volume
378
Financials
- Market Capitalization 1.1 B
- Employee 113
- Founded 2017
- CEO N/A
- Website www.januxrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZHSKH11
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.54
Price to sales ratio
85.51
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2362 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.66 USD | -4.61% | -6.37% | -38.55% | +20.88% | 1.17 B USD | ||
| 2380 |  KURA Kura Oncology, Inc. - Common Stock | 12.64 USD | -4.10% | +6.31% | +36.21% | +55.47% | 1.12 B USD | ||
| 2409 |  SVRA Savara, Inc. - Common Stock | 5.26 USD | -4.19% | -5.90% | -0.19% | +60.86% | 1.08 B USD | ||
| 2422 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 19.61 USD | -2.19% | -1.11% | -0.36% | +108.17% | 1.05 B USD |
Frequently asked questions about Janux Therapeutics, Inc. Common Stock
What is the Janux Therapeutics, Inc. Common Stock stock price today?
The current price of Janux Therapeutics, Inc. Common Stock (JANX) is 18.01. Over the past 24 hours, the stock has changed by -4.10%. Follow the JANX chart for real-time price dynamics.
What is the stock ticker of Janux Therapeutics, Inc. Common Stock?
Janux Therapeutics, Inc. Common Stock trades under the ticker JANX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Janux Therapeutics, Inc. Common Stock stock going up?
JANX has changed by +3.57% over the last week, +20.71% over the last month, and -22.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Janux Therapeutics, Inc. Common Stock?
Janux Therapeutics, Inc. Common Stock currently has a market capitalization of 1.1 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Janux Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Janux Therapeutics, Inc. Common Stock reported earnings of -0.35 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Janux Therapeutics, Inc. Common Stock revenue for the last quarter?
Janux Therapeutics, Inc. Common Stock reported quarterly revenue of 10.27 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Janux Therapeutics, Inc. Common Stock net income for the last quarter?
Janux Therapeutics, Inc. Common Stock reported net income of -21.97 M for the last quarter. The previous quarter showed -24.36 M, which means net income changed by +9.81%.
How many employees does Janux Therapeutics, Inc. Common Stock have?
As of the latest available data, Janux Therapeutics, Inc. Common Stock has 113 employees. Workforce size can provide additional context about the company's scale and operations.
What is Janux Therapeutics, Inc. Common Stock EBITDA?
Janux Therapeutics, Inc. Common Stock EBITDA is -45.08 M, and its EBITDA margin is -439.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Janux Therapeutics, Inc. Common Stock stock?
You can buy Janux Therapeutics, Inc. Common Stock (JANX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Janux Therapeutics, Inc. Common Stock stock?
Investing in Janux Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the JANX chart and related analysis on metatrader.com as part of your research.